Static and dynamic pupillary features in graves disease without orbitopathy

被引:0
|
作者
Kuskonmaz, Serife Mehlika [1 ]
Kocer, Ali Mert [2 ]
Onder, Cagatay Emir [1 ]
Sekeroglu, Mehmet Ali [3 ]
机构
[1] Ankara Numune Training & Res Hosp, Dept Endocrinol & Metab Dis, Ankara, Turkiye
[2] Ulucanlar Eye Training & Res Hosp, Dept Ophthalmol, Ankara, Turkiye
[3] Bilkent City Hosp, Dept Ophthalmol, Ankara, Turkiye
关键词
Static pupillary measurements; Dynamic pupillary measurements; Thyroid eye disease; Graves disease; Hyperthyroidism; SYMPATHETIC OVERACTIVITY; PUPILLOMETRY;
D O I
10.1007/s10792-024-03355-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PurposePupillary contraction and dilatation are organized by the autonomic nervous system, which can also be affected by Graves' disease (GD). In this study, it was aimed to investigate the static and dynamic pupillary responses of Graves' patients in the hyperthyroid and euthyroid periods and to compare these results with the values obtained from healthy controls. Methods48 eyes of 24 newly diagnosed Graves' patients with clinical activity score <= 2 and 46 eyes of 23 age- and sex-matched healthy controls were included in the study. Patients with GD were evaluated separately in the hyperthyroid phase and after euthyroidism was achieved. After a detailed ophthalmological examination, patients undergone automatic quantitative testing to obtain static (scotopic, mesopic, low photopic, and high photopeak pupil diameters) and dynamic (pupillary contraction amplitude, latency, velocity and duration, and pupil dilation latency, velocity and duration) pupil measurements. ResultsA statistically significant difference was found between the control [4.7 mm (3.7-6.9)] and hyperthyroid [5.1 mm (3.6-7.8)] groups for mesopic pupil diameter (p = 0.003). Dynamic pupillometry measurements showed that hyperthyroid and euthyroid groups had greater pupil dilation delay and lower pupil dilation rate compared to the control group (p < 0.05 for all). ConclusionEven in the absence of orbitopathy, patients with GD have autonomic dysregulation of pupillary functions. These changes, which prevail in the hyperthyroid phase, do not reverse when the TSH receptor antibody titer drops and the patient becomes euthyroid. Future studies are needed to elucidate the mechanism of these pupillary changes in GD.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Serum thyroglobulin is associated with orbitopathy in Graves' disease
    Khamisi, S.
    Lundqvist, M.
    Emadi, P.
    Almby, K.
    Ljunggren, O.
    Karlsson, F. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (09) : 1905 - 1911
  • [32] Teprotumumab: a disease modifying treatment for graves’ orbitopathy
    Michelle Ting
    Daniel G. Ezra
    Thyroid Research, 13
  • [33] Antigen-specific therapy of Graves' disease and orbitopathy by induction of tolerance
    Ungerer, Martin
    Fassbender, Julia
    Holthoff, Hans-Peter
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2018, 23 : 2044 - 2052
  • [34] Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?
    Anagnostis, P.
    Boboridis, K.
    Adamidou, F.
    Kita, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (03): : 257 - 261
  • [35] Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
    Villagelin, Danilo
    Romaldini, Joao
    Andrade, Juliana
    Santos, Roberto
    Milkos, Ana
    dos Santos Teixeira, Patricia Fatima
    Ward, Laura S.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [36] THYROTROPIN-RECEPTOR ANTIBODIES, IMMUNOGLOBULIN E AND ANTINUCLEAR ANTIBODIES IN PATIENTS WITH GRAVES' DISEASE AND GRAVES' ORBITOPATHY
    Stoynova, M.
    Shinkov, A.
    Kirilov, G.
    Kovatcheva, R.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2021, 17 (02) : 194 - 199
  • [37] Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease
    Lazarus, John H.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 26 (03) : 273 - 279
  • [38] Factors associated with severity of orbitopathy in patients with Graves' disease
    Nabi, Tauseef
    Rafiq, Nadeema
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2020, 10 (03) : 197 - 202
  • [39] Current Insights into Animal Models of Graves' Disease and Orbitopathy
    Wiesweg, B.
    Johnson, K. T. M.
    Eckstein, A. K.
    Berchner-Pfannschmidt, U.
    HORMONE AND METABOLIC RESEARCH, 2013, 45 (08) : 549 - 555
  • [40] Ocular surface disease index in Graves' orbitopathy: a cross-sectional study
    Maglionico, Maria Novella
    Lanzolla, Giulia
    Figus, Michele
    Cosentino, Giada
    Comi, Simone
    Marino, Michele
    Santini, Ferruccio
    Posarelli, Chiara
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15